Cortex Pharmaceuticals, Inc. (COR) Reacquires all AMPAKINE(R) Compounds, Related Patents and Exclusive Global Rights for Respiratory Depression from Biovail Laboratories Inc.
3/16/2011 6:57:55 AM
More...
|
Valeant Pharmaceuticals International (VRX) Announces License Of ACZONE(R) (dapsone) Gel 5% In Canada by Biovail Laboratories Inc. From Allergan Inc. (AGN)
2/8/2011 7:19:39 AM
More...
|
ACADIA Pharmaceuticals, Inc. (ACAD) Enters Agreement with Biovail Laboratories Inc. to Conclude Collaboration and Regain North American Rights to Pimavanserin; Acadia Receives $8.75 Million
10/28/2010 6:21:58 AM
More...
|
Biovail Laboratories Inc. Merger with Valeant Pharmaceuticals International (VRX) to Prompt 15-20% Headcount Cut
6/22/2010 8:12:30 AM
More...
|
Alexza Pharmaceuticals, Inc. (ALXA) Inks Deal with Biovail Laboratories Inc. for Anti-Psychotic Drug; Alexza to Get $40 Million Upfront
2/10/2010 6:59:27 AM
More...
|
MedGenesis Therapeutix Announces Agreements With Amgen (AMGN) (JOBS) and Biovail Laboratories Inc.
1/12/2010 7:06:11 AM
More...
|
Flamel Technologies (FLML) Announces Termination Of Licensing Agreement With Biovail Laboratories Inc. For Genvir And Recovery Of Rights
10/19/2005 5:12:55 PM
More...
|